0001179110-15-008668.txt : 20150528 0001179110-15-008668.hdr.sgml : 20150528 20150528161757 ACCESSION NUMBER: 0001179110-15-008668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150526 FILED AS OF DATE: 20150528 DATE AS OF CHANGE: 20150528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 22 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 9787775410 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MINOGUE MICHAEL R CENTRAL INDEX KEY: 0001286370 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 15895715 MAIL ADDRESS: STREET 1: 22 CHERRY HILL DR STREET 2: C/O ABIOMED INC CITY: DANVERS STATE: MA ZIP: 01923 4 1 edgar.xml FORM 4 - X0306 4 2015-05-26 0 0000815094 ABIOMED INC ABMD 0001286370 MINOGUE MICHAEL R C/O ABIOMED, INC., 22 CHERRY HILL DRIVE DANVERS MA 01923 1 1 0 0 President, CEO, Chairman Common Stock $.01 par value 2015-05-26 4 S 0 12569 60.0309 D 312220 D Common Stock $.01 par value 2015-05-26 4 S 0 1824 60.8798 D 310396 D Common Stock $.01 par value 2015-05-26 4 S 0 1596 61.8675 D 308800 D Common Stock $.01 par value 2015-05-14 5 G 0 E 20660 0 D 288140 D Common Stock $.01 par value 2015-05-26 5 G 0 E 33244 0 D 254896 D Common Stock $.01 par value 2015-05-14 5 G 0 E 20660 0 A 20660 I By Trust Common Stock $.01 par value 2015-05-26 5 G 0 E 33244 0 A 53904 I By Trust Common Stock $.01 par value 2015-05-27 5 G 0 E 33000 0 D 20904 I By Trust Stock Option (right to buy) 13.57 2007-06-01 2016-06-01 Common Stock 0 82000 D Stock Option (right to buy) 13.80 2009-05-23 2018-05-23 Common Stock 0 28333 D Stock Option (right to buy) 18.63 2009-06-15 2018-08-13 Common Stock 0 76875 D Stock Option (right to buy) 5.86 2010-05-28 2019-05-28 Common Stock 0 146800 D Stock Option (right to buy) 5.86 2010-05-28 2019-05-28 Common Stock 0 56700 D Stock Option (right to buy) 10.03 2011-06-03 2020-06-03 Common Stock 0 105000 D Stock Option (Right to Buy) 22.44 2013-05-22 2022-05-22 Common Stock 0 50000 D Stock Option (Right to Buy) 23.15 2014-05-14 2024-05-14 Common stock 0 21250 D Stock Option (right to buy) 21.55 2015-05-14 2024-05-14 Common Stock 0 85000 D Stock Option (right to buy) 66.25 2016-05-13 2025-05-13 Common Stock 0 35000 D Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan. These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan. These options become exercisable based on the achievement of certain performance milestones. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6. Sale of common stock pursuant to reporting owner's 10b5-1 plan, solely for payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $59.5200 and $60.5100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $60.5400 and $61.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $61.6000 and $62.1400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer. This transaction represents the transfer of common stock by bona fide gift from the reporting person to the Renee D. Minogue Revocable Trust, Renee D. Minogue, trustee DTD 12/29/2005. This transaction represents the transfer of common stock by bona fide gift from the Renee Minogue Revocable Trust, Renee D. Minogue, trustee DTD 12/29/2005 to a charitable foundation. /s/ Stephen C. McEvoy (by power of attorney) 2015-05-28 EX-24 2 ex24minogue.txt LIMITED POWER OF ATTORNEY The undersigned does hereby appoint each of Stephen McEvoy, Ian McLeod and Loretta Wedge, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as a director or officer of ABIOMED, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in- fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, this power of attorney has been executed as of the 2nd day of October, 2008 and shall remain in full force and effect until withdrawn by the undersigned in writing. Signature: /s/ Michael R. Minogue Print Name: Michael R. Minogue